內科學-急性腎衰竭顧勇_第1頁
內科學-急性腎衰竭顧勇_第2頁
內科學-急性腎衰竭顧勇_第3頁
內科學-急性腎衰竭顧勇_第4頁
內科學-急性腎衰竭顧勇_第5頁
已閱讀5頁,還剩30頁未讀 繼續免費閱讀

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領

文檔簡介

內科學急性腎衰竭顧勇ARF1.Definitionandconcept2.Pathogenesis3.Pathologyandpathophysiology4.Acutetubularnecrosis5.SpecialtypeofARF6.HandlingofARFDefinitionofARFSyndromeQuickdeclineofGFRAseriesofclinicalmanifestationAccumulationofnitrogen-containingtastesIncidenceofARFCommonhospitalization:5%ICU:>30%;74:243FeaturesofARFKidney:completerestorationoffunctionHighincidenceofcomplicationHighmorbidity&mortalityOtherorgansdamageClassificationofARFPrerenal:Hypoperfusion,functionality:55%-60%Renal:35%-40%Postrenal:urinarytract:5%CausesofprerenalARFLowvolume:bleeding,lostfromG-I,kidney,skin,thirdspaceLowcardiacoutput:myocardium,valve,Systemicvasodilatation:medicine,infection,allergy,liverfailureRenalarterialsystole:shock,medicine,liverfailureRenalARFRenalgreatvesselsGlomeruleAcutetubularnecrosis:ischemia/poisoningTubulesandinterstitiumPostrenalARF

Position:UreterbladderneckAnteriorurethraCause:Stone,coagulatedblood,Crystal,edema,deligationTumor,fibrosis,stenosis,prostateglandetc.ATNPathologyPathophysiologyCourseofdiseaseDiagnosisanddifferentialdiagnosisComplicationDeclineofGFRinARFAbnormalrenalhemodynamicsTubularimpairment:obstruction,backflowage,multi-organinvolvedNoperipheralcelldamageandinflammationRenaleffectiveperfusionIncreaseGFR:expansionofafferentarterioleofglomerulus/increasedkfUremicpericarditisSurvivalrateNephrologist,UrolandRadiol:WorkhandinhandNecrosis&ApoptosisinARFapoptoticbody→phagocytosisBackflow:ImpairedintegrityofepithelialcellsNormalfreethyroxinePosition:IncidenceofARFQuickdeclineofGFRDependon:differentsite,toxinconcentration,timeFactorsinvolvedinrenalhemodynamicsEndothelin:increasingreceptorblockingEDNO:decreasingOthers:PlateletActivatingFactor(PAF)AdenosineMedullaedemaTubuloglomerularfeedback:TGFTubularimpairmentObstruction:CaducousepithelialcellsandcomponentsCastBackflow:ImpairedintegrityofepithelialcellsAccordingtohistology:tubularcellsfalloffandnecrosis,castMetabolicchangeaftertubularcelldamageDecreasedATPCellularswellingIncreasedintracellularcalciumIntracellularacidosisActivationofphosphatidaseActivationofproteaseOxidativestressConsequenceofdamagedtubularcellsIntactSublethalDeath:Apoptosis/necrosisDependon:differentsite,toxinconcentration,timeNecrosis&ApoptosisinARFNecrosis:cellularswelling,chondriosomechangeDestroymembranousIntegrityReleaseproteinlysaseperipheralcelldamage/inflammationApoptosis:Activeenergyconsumptionprocesscellnucleusshrinkage→smallDNAfragmentcellmembrane:blebbingbutintegrityapoptoticbody→phagocytosisNoperipheralcelldamageandinflammationDependonseverityofimpairmentRepair,RegenerationandRecoveryRecoveryofSublethalcellsScavengenecroticcellsandintracavitarycastsRegenerationofepithelialcells:replacenecroticandcaducouscellsTubularepithelialcellsintegrityandfunctionrestorationCourseofATNInitiation:noparenchymaimpairmentMaintenance:parenchymaimpairment:1-2weeks,maybe11monthsRecoveryPerspectivestudy:notprovedQuickdeclineofGFRAnti-ICAM-1EndothelinreceptorantagonistDependon:differentsite,toxinconcentration,timeRecoveryofSublethalcellsClassificationofARFWoundinfectionsPeritonealdialysisMyocardialinfarctionPostrenalARFVolumecontrol/toxincleaningcellmembrane:blebbingbutintegrityActivationofphosphatidaseFactorsinvolvedinrenalhemodynamicsDiagnosisanddifferentialdiagnosisofATNDiagnosis:medicalhistory,physicalexamination,UrineAnalysis,bloodtestOtherexaminationspastmedicalhistory,drughistoryDifferentialdiagnosis:AcuteorChronicClassificationCausesSpecialtypeofARFTumorRenaltransplantationPregnancyLungdiseasesOperationonvesselsofheartLiverdiseasesNephroticSyndromeDrugsWhykidneyeasytobedamagedbydrugs?Largevolumeofbloodflow:25-30%heartstrokevolumeActivemetabolismLargestendothelialcellsurfaceRichenzymaticsystemTranscellulartransportConcentrationfunctionMuchoxygenconsumption,littleoxygensupply(medulla)ComplicationofARF(1)MetabolicHyperkalemiaMetabolicacidosisHyponatremiaHyponatremiaHyperphosphatemiaHypermagnesemiaHyperuricemiaCardiovascularPulmonaryedemaArrhythmiasPericarditisPericardialeffusionHypertensionMyocardialinfarctionPulmonaryembolismPneumonitisGastrointestinalNauseaVomitingMalnutritionGastritisGastrointestinalulcersGastrointestinalbleedingStomatitisorgingivitisParotitisorpancreatitisComplicationofARF(2)NeurologicNeuromuscularirritabilityAsterxisSeizuresMentalstatuschangesSomenolenceComaHematologicAnemiaBleedingInfectiousPneumoniaWoundinfectionsIVinfectionsSepticemiaUrinarytractinfectionOtherHiccupsDecreasedinsulincatabolismMildinsulinresistanceElevatedPTHReduced1,25-dihydroxy-and25-hydroxycitaminDLowtotalT3/T4NormalfreethyroxineHandlingofARF(1)PrerenalRenaleffectiveperfusionFluidsupplement:Wholeblood,plasma,crystalfluidHeart:volumeload,arrhythmiaCirrhosisOthersHandlingofARF(2)Renal:Prevention:Prerenalfactors:volume,cardio-respiratoryfunctionUseofdrugsEspeciallyVasoactiveagentDiureticOthersNecrosis&ApoptosisinARFIncreasethevolumeEndothelinreceptorantagonistClassificationofARFVasoactiveagentDifferentialdiagnosis:AcuteorChronicMyocardialinfarctionEDNO:decreasingcellnucleusshrinkage→smallDNAfragmentRepair,RegenerationandRecoveryLargestendothelialcellsurfaceAnti-ICAM-1Obstruction:FactorsinvolvedinrenalhemodynamicsIncidenceofARFDopamine1-3ug/kg/minIncreaseRPFandGFRPerspectivestudy:notprovedArhythmia/myocardialischemiaANPIncreaseGFR:expansionofafferentarterioleofglomerulus/increasedkfInhibitsodiumtransport,decreaseoxygenconsumptionExperimentsshowedeffectiveNotclinicallyconfirmedDiureticLargedoseDecreasevolumeloadMortalityanddialysisrateunchangedMannitol:NoclinicalevidenceIncreasethevolumeLowsodium(shift)OthersGrowthfactor:Insulin-LikeG-FEndothelinreceptorantagonistRGDpolypeptide:inhibittubularobstructionATPsupplementScavengeROSLeukocyteadhensioninhibiting:Anti-CD18Anti-ICAM-1Anti-P-selectinONRESEARCHNOWSpecialtreatmentofARF(notATN)CorticosteroidImmunosuppressiveagentPlasmapheresisAntiplateletBloodpressurecontrolComplicationtreatmentMetabolism:water-electrolyte,acid-basebalanceNutritionAnaemiaDialysisQuestions:Prognosis?Style?Dosage?Indication?DialysisPeritonealdialysisAcuteintermittenthemodialysisChroniccontinuoushemofiltration/hemodialysisCrystal,edema,deligationCourseofATNDependonseverityofimpairmentSpecialtreatmentofARF(notATN)WoundinfectionsConsequenceofdamagedtubularcellsCausesofprerenalARFapoptoticbody→phagocytosisTubularimpairmentCardiovascularfunctionunstableEndothelinreceptorantagonistAnti-ICAM-1Principle:TorelieveobstructionassoonaspossibleAccumulationofnitrogen-containingtastesHyperphosphatemiaDialysisAbsoluteIndicationsOliguria,urinaryvolume<500ml/dAnuria,>12hBUN>30mmol,Scr>1000μmol/LPneumonedema,noresponsetodiureticUremicencephalopathyUremicpericarditisIndicationo

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
  • 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
  • 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論